SCHEMBL2891648

SCHEMBL2891648

Cc1c(NS(C)(=O)=O)ccc2c1OC(C)(C)C(O)C2NC(=O)OCCc1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
NAAA Q02083 5/20 0.39
KCNA5 P22460 2/20 0.39
CYP19A1 P11511 1/20 0.38
NR3C1 P04150 1/20 0.38
IDO1 P14902 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2889371 0.87 NAAA (0.42) NAAAIDO1
SCHEMBL2883698 0.84 IDO1 (0.43) KCNA5NR3C1IDO1
SCHEMBL2883701 0.84 IDO1 (0.43) KCNA5NR3C1IDO1
SCHEMBL2889490 0.82 ALDH1A1 (0.40) NAAA
SCHEMBL2889177 0.82 KCNA5 (0.40) NAAAKCNA5
SCHEMBL2889180 0.82 KCNA5 (0.40) NAAAKCNA5
SCHEMBL2883993 0.81 KCNA5 (0.41) KCNA5CYP19A1
SCHEMBL2891644 0.81 KCNA5 (0.42) KCNA5NR3C1
SCHEMBL2891660 0.76 NAAA (0.41) NAAAKCNA5NR3C1
SCHEMBL2889226 0.75 KCNE1 (0.41) NAAAKCNA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7781483-B2 Benzopyran compound NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2010-08-24 US disclosed
US-20070299130-A1 Benzopyran Compound NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2007-12-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070299130-A1 Benzopyran Compound NR0B1, CYP2B6, RYR2 NAAA 3819/4885KCNA5 69/4885CYP19A1 1048/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.